New European exhibition launch for pharma industry
Inefficient processes, legacy infrastructure and a silo culture are slowing access to critical trial data.
Pharma companies need to ‘get with the programme’ in communications, says EACA’s Dominic Lyle.
M3 is strengthening and growing its global operations
Kyu Rhee, chief health officer, speaks about the company’s impact and aspirations in health.
System promises improvements in clinical trial verification and anti-counterfeiting.
A new whitepaper presenting analysis of exclusive M3 (EU) data, revealing the digital and technological habits and preferences of doctors and how pharma can best engage.
Trump makes vague promise to “reform” FDA – but how?